Bone Biologics Corporation Share Price
Equities
BBLG
US0980705018
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.595 USD | +4.25% | -0.31% | -64.71% |
01/03 | Bone Biologics Corporation Reports Progress with NB1 Clinical Program | CI |
21/02 | Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.35M 112M |
---|---|---|---|---|---|
Net income 2024 * | -8M -667M | Net income 2025 * | -8M -667M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.05
x | P/E ratio 2025 * |
-0.05
x | Employees | 2 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.85% |
1 day | +4.25% | ||
1 week | -0.31% | ||
Current month | -25.12% | ||
1 month | -25.12% | ||
3 months | -54.69% | ||
6 months | -62.38% | ||
Current year | -64.71% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Frelick
CEO | Chief Executive Officer | 59 | 17/15/17 |
Deina Walsh
DFI | Director of Finance/CFO | 60 | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Stroever
BRD | Director/Board Member | 75 | 01/12/01 |
Don Hankey
CHM | Chairman | 81 | 16/18/16 |
Robert Gagnon
BRD | Director/Board Member | 49 | 08/01 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 1.595 | +4.25% | 16 106 |
26/24/26 | 1.53 | +0.66% | 28,507 |
25/24/25 | 1.52 | -0.33% | 15,177 |
24/24/24 | 1.525 | -4.68% | 60,412 |
23/24/23 | 1.6 | 0.00% | 26,532 |
Delayed Quote Nasdaq, April 29, 2024 at 11:33 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.71% | 1.35M | |
+12.94% | 128B | |
-8.76% | 10.65B | |
+3.60% | 8.82B | |
+18.38% | 7.19B | |
+22.13% | 4.99B | |
+7.44% | 3.4B | |
+0.29% | 3.03B | |
-4.80% | 2.14B | |
-4.72% | 2B |
- Stock Market
- Equities
- BBLG Stock